會議論文(112.01~112.12)
| 篇序 | 作者姓名 (順位) |
論文題目 | 發表學會 或 會議名稱 |
起迄時間 | 地點 |
|---|---|---|---|---|---|
| 1 | 王憲奕(C) | Analysis of COVID-19 vaccination rate and infection rate among peritoneal inpatients in a southern medical center | 2023腎臟醫學會年會 | 1121209-1121210 | 台北 |
| 2 | 王憲奕(C) | Biosimilar recombinant human erythropoietin (UB-851) versus Reference Eprex® in Hemodialysis Patients with Renal Anemia: A Multicenter, Randomized, Double-Blinded, Phase III Trial In Taiwan | 2023腎臟醫學會年會 | 1121209-1121210 | 台北 |
| 3 | 甘偉志(C) |
High glucose and advanced glycation end products may induce renal fibrosis via regulation of NR4A1 and FUBP1 高萄葡糖與糖化終產物可能透過調控NR4A1和FUBP1誘發腎臟纖維化 |
2023腎臟醫學會年會 | 1121209-1121210 | 台北 |
| 4 | 簡志強(1) | 無症狀鹿角結石之糖尿病患，同時併產氣性腎盂腎炎、輸尿管炎及膀胱炎 | 台灣內科醫學會年會 | 1121202-1121203 | 台北 |
| 5 |
江銘彥 |
Long-term evolution of kidney function in chronic hepatitis C patients with sofosbuvir‑based or sofosbuvir‑free direct-acting antivirals | International Society of Nephrology (WCN’23) | 1120330-1120402 |
泰國曼谷 |
| 6 | 江銘彥 (1, C) |
Burden of Guillain-Barré syndrome in Taiwan, South Korea, and Japan: findings from Global Burden of Disease Study 2019 | 2023急重症聯合學術年會 | 1121014-1121015 | 台北 |
| 7 | 江銘彥(C) | Association of vitamin D deficiency with risk of tuberculosis and subsequent long-term mortality: a population-based cohort study in the United States | 台灣內科醫學會年會 | 1121202-1121203 | 台北 |
| 8 | 江銘彥(C) | Association of sedentary lifestyle with all-cause and cause-specific mortality in adults with reduced kidney function | 台灣內科醫學會年會 | 1121202-1121203 | 台北 |
| 9 | 江銘彥(C) | Association of heavy metal exposure with risk of chronic kidney disease and subsequent long-term mortality: a population-based cohort study in the United States | 台灣內科醫學會年會 | 1121202-1121203 | 台北 |
| 10 | 江銘彥(C) | Burden and trend of cirrhosis in Taiwan, South Korea, and Japan, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 | 台灣內科醫學會年會 | 1121202-1121203 | 台北 |
| 11 | 江銘彥 (1, C) |
Association of non-alcoholic fatty liver disease and liver fibrosis with kidney disease risk | 2023腎臟醫學會年會 | 1121209-1121210 | 台北 |
| 12 | 江銘彥 (1, C) |
Impact of national hepatitis C virus (HCV) elimination policies and actions on HCV micro-elimination in hemodialysis population | 2023腎臟醫學會年會 | 1121209-1121210 | 台北 |
| 13 | 陳銳溢(1) | Beneficial Outcomes of Angiotensin Receptor-Neprilysin Inhibitors in Individuals with Heart Failure and Acute Kidney Disease | 2023APAC | 2023.09.24 | 韓國大邱 |
| 14 | 陳銳溢(1) | Beneficial Outcomes of Angiotensin Receptor-Neprilysin Inhibitors in Individuals with Heart Failure and Acute Kidney Disease | 2023腎臟醫學會年會 | 2023.12.10 | 台北 |
| 15 | 陳銳溢(1) | Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis | 2023腎臟醫學會年會 | 2023.12.10 | 台北 |
| 16 | 陳銳溢(C) | Outcomes associated with immune checkpoint inhibitors related adverse kidney events: a systematic review and meta-analysis | 2023腎臟醫學會年會 | 2023.12.10 | 台北 |
| 17 | 陳銳溢(C) | Secondary Membranous Nephropathy with “Full-House” Pattern in a early Syphilis Infection | 2023台灣腎臟醫學會南部地方會 | 2023.06.18 | 高雄 |
| 18 | 楊翼寧(C) | Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease | 台灣內科醫學會年會 | 1121202-1121203 | 台北 |
| 19 | 楊翼寧(C) | Combining artificial intelligence risk prediction systems and nursing intervention effectively reduces the incidence of intradialytic hypotension | 2023腎臟醫學會年會 | 1121209-1121210 | 台北 |
| 20 | 楊翼寧(C) | 明智選擇(Choosing Wisely): 你可以『不』洗腎- NO ACT IS ACT | 2023腎臟醫學會年會 | 1121209-1121210 | 台北 |
| 21 | 黃筠婷(2) | Factors Associated with Faster residual Renal Function decline in pre-ESRD patients 探討影響末期腎臟病前期之病人殘餘腎功能較快速惡化的因子 | 2023腎臟醫學會年會 | 1121209-1121210 | 台北 |